> ## Content Index
> Fetch the complete content index at: https://venture-block.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Oura buys Counsel Health for $625M to add AI doctors to its smart ring app
- URL: https://venture-block.com/oura-acquires-counsel-health-625m-ai-primary-care/
- Published: 2026-11-11T14:07:59.000Z
- Updated: 2026-11-11T14:07:59.000Z
- Description: The smart ring maker will pay $625 million in cash for the AI-plus-physician care startup it built into its app in June, six weeks after postponing its IPO.
- Author: Venture Block
- Tags: Funding, Science

Oura, the maker of the smart ring, has agreed to buy Counsel Health, an AI-native primary care company, for [$625 million in cash](https://www.counselhealth.com/newsroom/oura-to-acquire-counsel-health-advancing-vision-for-more-connected-personalized-healthcare?ref=venture-block.com), subject to purchase price adjustments. The companies announced the deal on Nov. 10 and said they expect it to close before the end of the calendar year, subject to customary conditions.

The purchase comes six weeks after Oura [postponed its Nasdaq IPO](https://www.cnbc.com/2026/09/29/smart-ring-maker-oura-postpones-ipo-due-to-market-uncertainty.html?ref=venture-block.com), citing uncertainty in the IPO market. Instead of raising new money in public markets, Oura is now spending cash to move from measuring the body to treating it.

## What Counsel actually does

Counsel pairs a medical chatbot with its own physicians. A patient starts by chatting with Counsel's AI, which the company says draws on connected medical records, prior conversations, clinical guidelines and continuous biometric data. At any point the patient can bring in a board-certified Counsel doctor, who can diagnose, prescribe and refer.

Under the hood, Counsel describes a "clinical AI harness" that calls specialized agents for separate jobs: taking a medical history, retrieving guidelines, reviewing records and detecting emergencies. Each agent is evaluated for performance and safety and refined with feedback from Counsel's doctors, according to the announcement. Physicians work in a tool Counsel calls the Clinician Cockpit, which summarizes a patient's record and long-term health trends and suggests next steps.

The company sells mainly through enterprise partners, including health plans, health systems, employers and consumer health companies. When it raised a [$25 million Series A](https://www.counselhealth.com/newsroom/25m-series-a-to-scale-ai-enabled-physician-supervised-virtual-care?ref=venture-block.com) led by Andreessen Horowitz and GV in October 2025, Counsel said it served more than 100,000 members and ran a physician-led medical group licensed in all 50 states. That round followed an $11 million seed led by a16z in October 2024\. PitchBook estimates Counsel raised about $36 million in total, [TechCrunch reported](https://techcrunch.com/2026/11/10/oura-to-acquire-ai-native-primary-care-startup-counsel-health-for-625m/?ref=venture-block.com).

## From partner to owner

The two companies already work together. In June, Oura [built Counsel into its app](https://ouraring.com/blog/counsel-integration-oura-app/?ref=venture-block.com): members can tap from a health alert into Counsel's medical AI, and pay $159 a year for unlimited access to the AI and its doctors, who can see the member's Oura trends with consent. Oura says more than 90 percent of surveyed members using Counsel said their Oura data helped them get better care, and members who saw a Counsel physician rated the experience 4.6 out of 5.

Under the deal, Counsel founder and CEO Muthu Alagappan will join Oura as chief clinical AI officer, along with Counsel's 70 employees, according to Bloomberg as cited by TechCrunch. Counsel says it will keep serving its enterprise partners, and that its platform will not require customers [to have or buy an Oura Ring](https://www.counselhealth.com/resources/reimagining-primary-care-with-oura?ref=venture-block.com).

Executive chairman David Shuman framed the price as an expansion of Oura's market. "Counsel's enterprise partners also open the door to millions of people beyond our existing member base," he said in the release.

## The numbers behind the bet

Oura paired the announcement with preliminary, unaudited results for its fiscal fourth quarter, which ended Sept. 30\. Revenue rose 153 percent from a year earlier to $533 million, and the company reported $87 million of adjusted EBITDA, a 16 percent margin. Revenue for fiscal 2026 came to about $1.75 billion, up 92 percent, and Oura says it has more than six million members.

Those figures matter because of how the IPO ended. Oura had marketed the offering at $40 to $44 a share to raise up to about $2.2 billion, a deal that would have implied a fully diluted valuation above $15 billion at the top of the range, [Fortune reported](https://fortune.com/2026/10/06/why-did-oura-pull-its-ipo/?ref=venture-block.com). Some prospective buyers walked away over the valuation and the large share of stock being sold by existing holders, according to Bloomberg reporting cited by Fortune. Oura was last valued privately at about $11 billion after a $900 million round in October 2025.

Counsel gives Oura a services business on top of hardware and subscriptions at a time when smart ring rivals such as RingConn and Ultrahuman are competing for the same buyers. Wearable makers have moved in this direction before: Samsung [bought digital health platform Xealth](https://venture-block.com/samsung-acquires-xealth-a-bold-move-to-transform-digital-healthcare-ecosystem/) last year to connect its devices to care providers. Oura's own materials note that its ring is not a medical device; the clinical side of the combined offer runs through Counsel's licensed physicians.

The deal also lands in a busy stretch for late-stage listings: Anthropic set a price range for its own [Nasdaq IPO](https://venture-block.com/anthropic-s1-ipo-nasdaq-ant-revenue/) this week, while Oura has not given a new timeline for its offering. The Counsel acquisition is expected to close by the end of 2026.